RegAudit RWE local-first regulatory readiness product concept
Coming soon - private beta access list now open
Coming soon

Traceable regulatory readiness packages, preparing for private beta.

RegAudit RWE is a local-first product environment for organizing source references, document findings, redline recommendations, clean drafts, and qualified-review handoffs. Join the access list for product updates while regulated document work stays inside authorized private workspaces.

Local-first - private - regulatory ready

RegAudit RWE

Transform regulatory complexity into clear, auditable evidence with source-linked findings, controlled review gates, and reviewer-ready outputs.

Evidence traceable Source linked Privacy by design Built for review
No FDA review, approval, clearance, acceptance, compliance certainty, or regulatory determination.
19SourcesIn library
22Monitored targetsActively tracked
QAReviewer gateRequired before use
LocalProcessingPrivate by default
FDA21 CFR, RWD/RWE guidance, final delivery controls
GAMP 5Listed as optional licensed reference, not bundled in v1
ICHClinical evidence and study reporting context
EUPrivacy and device readiness context
Authorized workspace preview
Document intake lives inside the private workspace DOCX / PDF / XLSX / CSV / TXT
Review route, source map, findings, redlines
W
SOP-ERS-2024-001_Electronic_Records.docx Example controlled document preview
Locked
Standard Operating Procedure (SOP) v
Reviewer packet first v
Private beta access required
Review -> Findings -> Redlines -> Corrected Document

Product workflow

Designed to organize the review package, not replace the reviewer.

The public page explains the product. The private workspace performs controlled document intake, rule mapping, findings, redlines, and reviewer handoff.

01

Classify the document

Identify file type, review pathway, sensitivity status, and expected output package before analysis begins.

02

Map source requirements

Use a local versioned source library and deterministic rules before any optional AI support is considered.

03

Create review evidence

Produce risk-coded findings, source references, comments, and proposed revision language for human review.

04

Package for approval

Prepare editable drafts, redlines, clean copies, PDF reports, and audit trail records for qualified reviewer approval.

Source library

Official references stay visible and version-aware.

RegAudit separates source-linked review from unsupported assumptions. When a monitored source changes, it requires human review before rules are updated.

FDA RWD/RWE guidanceLocal libraryTracked
21 CFR and electronic recordsRegulatory mapTracked
Digital health and remote acquisitionEvidence contextTracked
eCFR and Federal Register monitorsWeb/API checkTracked
19Sources in current local library
22Official targets monitored for version changes
0Current sources requiring review in the last check

Review package outputs

Built around evidence, redlines, and document control.

Every output should be editable where appropriate, exportable when authorized, and traceable to the source snapshot used during review.

Finding table

Severity, document section, source basis, evidence, remediation, and reviewer status.

Redline draft

Proposed revisions with comments tied to source references and finding IDs.

Clean copy

Editable corrected document after accepted changes and review controls.

PDF report

Readiness score, source map, findings summary, and reviewer acknowledgement.

Audit trail

Control number, timestamp, source snapshot, reviewer route, and package version.

Commercial packaging concept

Start private. Scale when the product is ready.

These are positioning tiers for a future commercial site, not active public purchase flows.

Private Workspace

For personal/local use and early product validation.

  • Local source library
  • Document review package preview
  • Manual reviewer approval gate

Enterprise Library

For teams that need policies, templates, libraries, and review routing.

  • Team review gates
  • Custom source library controls
  • Submission package governance

Safety boundaries

Conservative claims by design.

The product should accelerate review preparation without claiming regulatory approval, acceptance, clearance, or certainty.

No regulatory determination

RegAudit does not provide FDA review, approval, clearance, acceptance, compliance certainty, or regulatory determination.

Human approval required

Generated material is reference support only and requires qualified/certified reviewer approval before use.

Source versioning required

Official references should be checked before final outputs, and changed sources require human review.

RegAuditRWE.com

Coming soon for private beta access.

Use the public site to introduce the product and collect qualified interest. The actual workspace remains gated, private, and reviewer-controlled until deployment controls are ready.

Email capture is prepared for the public domain launch.

Direct contact: contact@regauditrwe.com